Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Amlodipine/Benazepril vs Amlodipine in Hypertension
NCT00171366Phase 3Completed
- Sponsor
- Novartis
- Start
- Jul 2004
- Primary completion
- Jul 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of benazepril in hypertension (HTN) (2 arms), sponsored by Novartis. Primary endpoint: Change from baseline in mean sitting diastolic blood pressure at 6 weeks. Started Jul 2004; status: completed.
02
Drugs
benazepril
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on NCT00171366.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00171366.